Medley

Medley FCF Yield

The Free Cash Flow Yield of Medley (4480.T) as of Nov 4, 2026 is 4.66 %. In the previous year, Free Cash Flow Yield was 3.38 % — a change of 37.80% (higher).

FCF Yield

4.66 %

YoY

37.80%

Last updated:

Free Cash Flow Yield of Medley is 2025 4.66 % . Free Cash Flow Yield of Medley was 2024 3.38 % . It decreases by 37.80% higher compared to the previous year.

The Medley FCF Yield history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

FCF Yield
Date
FCF Yield
Jan 1, 2018
-0.01 JPY
Jan 1, 2019
0.49 JPY
Jan 1, 2020
0.84 JPY
Jan 1, 2021
1.13 JPY
Jan 1, 2022
2.32 JPY
Jan 1, 2023
4.92 JPY
Jan 1, 2024
3.38 JPY
Jan 1, 2025
4.66 JPY
The Medley FCF Yield history
YEARFCF YieldYoY
4.66 %+37.80%
3.38 %-31.34%
4.92 %+112.11%
2.32 %+105.30%
1.13 %+34.56%
0.84 %+70.67%
0.49 %-4,890.54%
-0.01 %-120.30%
0.05 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Medley Stock analysis

What does Medley do? Medley Inc is a global company specializing in the production and sale of pharmaceutical products. The company was founded in 1985 as a small business and has since become a leading player in the pharmaceutical industry, operating in over 150 countries. Medley Inc produces a variety of products in different areas such as cardiology, gastroenterology, oncology, orthopedics, neurology, and dermatology. The company's business model is based on the development and sale of generic products, which are imitation products of patented drugs. Medley Inc focuses on producing high-quality and effective medicines at competitive prices. The company has production sites in various countries to meet the demand for drugs in each region. In addition to being a manufacturer of medicines, Medley Inc also offers services such as drug distribution, clinical studies, research and development, consulting for pharmaceutical manufacturers, and customer training. The company places great importance on the quality and safety of its products and services and has implemented a comprehensive quality management system to meet its high standards. The product range of Medley Inc includes a variety of drugs used in different indications, including well-known drugs such as Tamoxifen for cancer, Fluoxetine for depression, Oxycodone for pain relief, and Levofloxacin as an antibiotic. Medley Inc strives to make affordable medications accessible to all people and works to improve healthcare worldwide. The company has formed long-term partnerships with organizations and governments in emerging countries to enhance access to affordable medicines. Overall, Medley Inc is a significant player in the pharmaceutical industry, focusing on the production of generics and improving healthcare globally. Through its efforts in quality, innovation, and partnerships, the company aims to have a positive impact on society. Medley is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Medley stock

Free Cash Flow Yield of Medley is 4.66 % in 2025.

Free Cash Flow Yield of Medley changed from 3.38 % to 4.66 %, representing a 37.80% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Free Cash Flow Yield Medley since 2006 – with annual values, charts, and detailed analysis.

FCF Yield measures the free cash flow per share relative to the stock price. It indicates how much cash a company generates for each dollar invested.

To evaluate Free Cash Flow Yield's, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Free Cash Flow Yield.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Free Cash Flow Yield's Medley with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Valuation — Medley

All Key Metrics — Medley